Odaily Noon Briefing
1. Only one person has been approved for Trump's "Golden Card" visa program, creating a stark contrast to the expectation of tens of billions of dollars;
2. Pump.fun has repurchased over 35% of the total circulating supply of tokens, with cumulative buybacks exceeding $360 million in value;
3. NVIDIA's market capitalization has once again surpassed $5 trillion;
4. The US military personnel who illegally profited $400,000 on Polymarket was previously denied account opening by Kalshi;
5. Financial reports disclose that Trump conducted dozens of bond trading transactions in March, totaling several million dollars;
6. Bitdeer continues to maintain zero holdings and sold 185.7 BTC this week;
7. Bitcoin developer Paul Sztorc plans to launch the eCash hard fork network in August, supporting 1:1 exchange with BTC, which has sparked community controversy;
8. Mango Markets attacker Avi Eisenberg's address has appeared on-chain again with a new signature, drawing community attention;
9. An early Ethereum whale has transferred 10,000 ETH to a multi-signature address and may sell in the near future;
10. An address linked to the Balancer attacker transferred 5,609 ETH worth $13 million to THORChain over the past 9 hours.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
